tradingkey.logo
tradingkey.logo
Pesquisar

Evotec SE

EVO
Adicionar à lista de desejos
2.700USD
-0.020-0.74%
Fechamento 05/15, 16:00ETCotações atrasadas em 15 min
954.92MValor de mercado
PerdaP/L TTM

Mais detalhes de Evotec SE Empresa

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Informações de Evotec SE

Código da empresaEVO
Nome da EmpresaEvotec SE
Data de listagemOct 11, 1999
CEOWojczewski (Christian)
Número de funcionários4827
Tipo de títulosDepository Receipt
Fim do ano fiscalOct 11
EndereçoEssener Bogen 7
CidadeHAMBURG
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísGermany
Código postal22419
Telefone4940560810
Sitehttps://www.evotec.com/
Código da empresaEVO
Data de listagemOct 11, 1999
CEOWojczewski (Christian)

Executivos da empresa Evotec SE

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Laetitia Rouxel
Ms. Laetitia Rouxel
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Mrs. Aurelie Dalbiez
Mrs. Aurelie Dalbiez
Chief People Officer, Member of the Management Board
Chief People Officer, Member of the Management Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2024
FY2023
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
United States
482.23M
55.94%
Switzerland
117.94M
13.68%
United Kingdom
100.06M
11.61%
Rest of the world
89.00M
10.32%
Germany
35.59M
4.13%
Outro
37.16M
4.31%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: qui, 14 de mai
Atualizado em: qui, 14 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Mubadala Investment Company PJSC
1.29%
Wellington Management Company, LLP
0.51%
DCF Advisers, LLC
0.30%
WCM Investment Management
0.18%
Parametric Portfolio Associates LLC
0.05%
Outro
97.67%
Investidores
Investidores
Proporção
Mubadala Investment Company PJSC
1.29%
Wellington Management Company, LLP
0.51%
DCF Advisers, LLC
0.30%
WCM Investment Management
0.18%
Parametric Portfolio Associates LLC
0.05%
Outro
97.67%
Tipos de investidores
Investidores
Proporção
Sovereign Wealth Fund
1.29%
Investment Advisor
0.74%
Investment Advisor/Hedge Fund
0.51%
Research Firm
0.07%
Hedge Fund
0.06%
Outro
97.33%

Participação acionária institucional

Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
81
9.58M
2.69%
-584.61K
2025Q4
76
9.39M
2.97%
--
2025Q3
77
9.39M
2.97%
-16.64K
2025Q2
74
9.40M
2.85%
+334.04K
2025Q1
60
9.08M
2.82%
-923.30K
2024Q4
59
8.93M
2.90%
+634.42K
2024Q3
56
8.37M
3.36%
+770.57K
2024Q2
55
7.62M
2.73%
+2.19M
2024Q1
54
5.00M
2.98%
-5.56M
2023Q4
57
5.71M
1.76%
+4.47M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Mubadala Investment Company PJSC
4.60M
1.29%
--
--
Dec 31, 2025
Wellington Management Company, LLP
1.80M
0.51%
+367.55K
+25.70%
Dec 31, 2025
DCF Advisers, LLC
1.20M
0.34%
--
--
Dec 31, 2025
WCM Investment Management
559.34K
0.16%
+259.07K
+86.28%
Dec 31, 2025
Parametric Portfolio Associates LLC
184.21K
0.05%
-40.74K
-18.11%
Dec 31, 2025
LPL Financial LLC
94.63K
0.03%
+18.96K
+25.06%
Dec 31, 2025
Envestnet Asset Management, Inc.
70.03K
0.02%
-5.68K
-7.50%
Dec 31, 2025
Millennium Management LLC
102.85K
0.03%
+102.85K
--
Dec 31, 2025
Citadel Advisors LLC
69.52K
0.02%
-26.53K
-27.62%
Dec 31, 2025
Morgan Stanley Smith Barney LLC
59.77K
0.02%
-15.06K
-20.13%
Dec 31, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
iShares Biotechnology ETF
0.08%
ActivePassive International Equity ETF
0%
DFA Dimensional Intl Sustainability Core 1 ETF
0%
iShares Biotechnology ETF
Proporção0.08%
ActivePassive International Equity ETF
Proporção0%
DFA Dimensional Intl Sustainability Core 1 ETF
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI